ArticleBrain and behavior2026
Associations of Weight and Glucose Levels With Myasthenia Gravis: A Two-Step, Two-Sample Mendelian Randomization and Retrospective Case-Control Study.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevious studies suggested links between obesity, glucose regulation, and autoimmune diseases, but the associations of weight and glucose levels with myasthenia gravis (MG) remain uncertain. We examined these associations and a potential indirect pathway through glucose levels.
objectiveWe investigated the associations of weight and glucose levels with MG risk using Mendelian randomization (MR) and a retrospective case-control study.
methodsWe conducted two-sample MR analyses using genome-wide association study summary statistics from European populations. The clinical component retrospectively included patients with MG and healthy controls and used propensity-score matching and logistic regression.
resultsThe MR analyses suggested associations among genetically predicted weight, glucose levels, and MG risk. They also yielded a small indirect estimate through glucose levels that was opposite in direction to the direct and total effects. This opposing-direction indirect estimate was sensitive to the inferential method and was not observed in the retrospective case-control analysis. In the clinical analysis, MG cases had higher weight and lower glucose levels than controls, and both variables were associated with MG status.
conclusionTwo-sample MR suggested that genetically predicted higher weight was associated with higher odds of MG, whereas genetically predicted higher glucose levels were associated with lower odds of MG. The retrospective case-control analysis showed directionally similar associations for measured weight and fasting glucose, but the indirect pathway suggested by MR was not observed in the clinical analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.